Updated initial conversion table based on clinical trials in adults showing significantly improved mealtime glycemic ...
A Roche cancer drug that treats lung cancer with a certain genetic signature now has an additional FDA approval that expands the applications of the blockbuster product. The drug, Alecensa, is already ...
AstraZeneca AZN announced that the FDA expanded the label of its blockbuster cancer drug Imfinzi for a fourth indication in lung cancer. The FDA approved Imfinzi in combination with platinum-based ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results